CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Antihistamine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000363
NCT00000363Phase 3Completed

Acute Otitis Media: Adjuvant Therapy to Improve Outcome

National Institute on Deafness and Other Communication Disorders (NIDCD)·interventional·Posted Nov 3, 1999·Updated Apr 24, 2006

In Brief

A Phase 3 clinical trial evaluating Antihistamine and Corticosteroid for Otitis Media. Completed, across 1 site.

Detailed Summary

Acute otitis media is one of the most common diseases of childhood and is one of the major causes of hearing loss in children. Despite the availability of effective antibiotic therapy for otitis media, treatment failures, persistent effusions, and recurrences are common. This Phase III outpatient study aims to test whether adjuvant therapy (an antihistamine or a corticosteroid), in addition to antibiotic therapy, improves the acute and long-term outcomes of patients with acute otitis media. This study is targeted to recruiting 200 infants (age less than one year); patient (and parent) participation is estimated to continue for one year after enrollment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOtitis Media
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 3, 1999
Study CompletionJun 1, 2001
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

Antihistaminedrug

Corticosteroiddrug